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Dealing with publication bias
There is a human trend to. pu~lish just clinic~l trialswith positive results. ThlS klnd of systematlc error. or bias tends to mislead the readers. Faults of this
nature are attributable to Editors' preferences for causing
scientific impact with their publications, but evidence has
also recently been put forward that the authors of clinicaI
trials which did not detect the effect of new treatment tend
not to submit the respective papers for publication 1.
The result is that when publication bias occurs, there
is the probability that the results of reviews will be
incorrect. Because of this, the Cochrane Collaboration
reviewers have taken on the commitment to search for all
existing clinicaI trials regarding a specific therapeutics
question, published or note In other words, the value of a
particular trial depends more on the methods included in
its design and development, than on what joumal it was
published in.
In order to contribute to this subject, the São Paulo
MedicaI Journal is joining the best international journals,
like the Lancet, the British MedicaI Joumal and the JAMA,
in the Unpublished Trials Amnesty Campaign. Brazilian
colleagues who have unpublished clinicaI trials may fill
in and retum the form included in this issue, or send the
full paper to the São Paulo MedicaI JournaI, so that they
will have a chance of being included in a publication or at
least in the Cochrane Database of ClinicaI Trials. Thus,
they will gain the visibility to be included in systematic
reviews and get citations and recognition. More details
may be obtained in the next paper by Iain Roberts and
Richard Smith, editor of the British MedicaI Journal.
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IIAn amnesty for unpublished trials. Send us details on any
unreported trials
This month over 100 medicaI journals around the
world are inviting readers to send information on
unpublished trials. This amnesty should have important
benefits for patients. Why?
Reports of properly conducted randomised controlled
trials are the foundation of effective health care, but many
are not submitted for publication 1,2 This reduces the power
of systematic reviews to detect moderate but clinically
important treatment effects. Patients may thus be denied
effective forms of health care. A second problem is that.
since triaIs that show more promising effects are more
IikeIy to be submitted, research syntheses can give
misleading conclusions about effectiveness. Patients may
thus be exposed to useless or even harmful treatments.3
Final1y, patients may be asked to participate in new studies
designed to address questions that have already been
answered.4
TriaIs go unreported for a myriad of reasons: it is
well documented that trials with non-significant results
are substantial1y less likely to be submitted for publication.1
Sometimes recruiting partici pants takes longer than
expected at the expense of time set aside for report writing;
investigators may change jobs and work remain unfinished;
or investigators may discover a recentIy published trial on
the same topic and conclude that their own results are
redundante Editors must also take some responsibility:
there is a limit to the number of reports we can publish.
Many investigators regret not having published their
resuIts, and when contacted almost all are delighted to
provide them.
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because of the serious implications of unreported research,
we are trying to cleave the trials from the tribulations. We
are confident of a good response."
Richard Smith - Editor, BMJ
Ian Roberts - Director
Child Health Monitoring Unit, Institute of Child
Health, London WCIN lEH
Although amnesty means giving pardon, we hope
that investigators will see this as an opportunity-namely,
to make the results of previously unreported trials publicly
accessible, thus having the potential to contribute to the
.. scientific foundation of health care. We urge alI
investigators with unreported trial data to register their
trials by returninga photocopy of the registration form
shown below. We would like to register any unreported
controlled trial, including trials that have ~nly been
published as an abstract.
Registration can be undertaken by anyone able to
provide the registration information, even if they cannot
provide the actual trial data. We expect a degree of
duplicate registration. The information will be made
available by listing the trial details on a web 'site and in
other ways. If specific trial data are required, for example .
by those conducting systematic reviews, then the reviewer 2.
will be able to seek this information directly from the
trialist. Some of the trials may be suitable for full
publication, and the journal will be happy to consider
these.
MedicaI editors are acutely aware of the trials and
tribulations of research reporting. On this occasion,
x- - - - - - - - - - - - - - - - - - - - - - -_.:.-- - - -.-':-"- - --
Unreported trial registration form
Register any controlled trial which has not been published in fu11, including trials that have been published only as an
abstract. Registratio~ can be undertaken by anyone able to provide registration information, even if they are unable to
provide the actual trial data. Please complete one form for each trial being registered.
Contact details
Surname:
Postal address: _
Forename~):_~~~~~~~~~~~~~_
Phone (with regional codes): ~ _
Fax (with regional codes): ~ -
Email: ~~~~~~~~~~~~~~~~_
Trial details
Approximate number of participants in the tria1"'lo.L. _
Type of participants (eg people with head injury, women at risk of breast cancer):-----------
Type of intervention (eg steroids versus placebo, annual mammography versus standard practice: _
____________________ versus _
Please post or fax registration forms to: MedicaI Editors' Trial Amnesty, BMJ Editorial Department, Tavistock
Square, London WCIH 9JR. Fax: 44 (O) 171 383 6418. Alternatively the information can be sent by email to:
meta@uc1.ac.uk
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